Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304026 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Theresa Pöschel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine II, Leipzig University Medical Centre, Leipzig, Germany. Hauptthemen laut MEDLINE: Image-Guided Biopsy, Liver Neoplasms, Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leipzig University supported by the German Research Foundation.
Themen: Patientensicherheit
Abstract (Originalsprache)
Purpose
Ultrasound-guided biopsy of focal liver lesions (FLL) is a well-established procedure with crucial impact on therapeutic decisions. The safety and accuracy depend on needle type, tumour location and comorbidities. Modern oncological concepts often require large tumour specimens which may increase the procedural risk. Materials and methods We retrospectively collected data from consecutively scheduled ultrasound-guided FLL biopsies performed in an interdisciplinary ultrasound unit at a university hospital from 2015–2020. We analysed complication rates, diagnostic accuracy, and patient outcome in a one-year period.
Results
Of 426 scheduled interventions, 339 were included: 322 primary biopsies (40% female, median age 65 years, median BMI 25.4 kg/m 2 ) and 17 rebiopsies in cases with undetermined diagnosis. Indications comprised 309 (96%) cases with suspected malignant lesions. Important comorbidities were type 2 diabetes (n = 107, 33%) and cirrhosis (n = 64, 20%). A conclusive histopathological diagnosis was achieved in 270 (84%) cases with a weak association with lesion size (OR 1.12 per cm, 95%CI 0.99–1.27). Greater BMI (OR 0.60 per 10 BMI points, 95%CI 0.34–1.05) showed a trend towards an insufficient diagnosis. Relevant complications occurred in 8 (2.5%) cases (2 major; 1 life-threatening). Multiple passes showed a trend towards adverse events (OR 2.32 for > 1 pass, 95%CI 0.99–5.42). 93 (29%) patients died during a median follow-up of 171 days.
Conclusion
Ultrasound-guided FLL biopsy is an efficient and safe diagnostic measure. The limitations of the procedure and its associated risks should be considered in patients with advanced malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine II, Leipzig University Medical Centre, Leipzig, Germany.
- Division of Interdisciplinary Ultrasound, Department of Internal Medicine I (Gastroenterology, Pneumology), University Hospital Halle, Halle (Saale), Germany.
- Institute of Pathology, Leipzig University Medical Centre, Leipzig, Germany.
- Division of Hepatology, Department of Medicine II, Leipzig University Medical Centre, Leipzig, Germany.
- Department of Internal Medicine, Community Hospital Delitzsch, Delitzsch, Germany.
ORCID-Profile: Theresa Pöschel, Johannes Wiegand, Thomas Karlas
Förderung
- Leipzig University supported by the German Research Foundation
Zitieren
APA
Pöschel, T., Blank, V., Schlosser, T., Lingscheidt, T., Böhlig, A., Wiegand, J., & Karlas, T. (2024). Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0304026
Vancouver
Pöschel T, Blank V, Schlosser T, Lingscheidt T, Böhlig A, Wiegand J, et al. Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0304026
BibTeX
@article{Pschel2024,
author = {Pöschel, Theresa and Blank, Valentin and Schlosser, Tobias and Lingscheidt, Thomas and Böhlig, Albrecht and Wiegand, Johannes and Karlas, Thomas},
title = {Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304026}
}
EUVIMED